These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8702656)

  • 1. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides.
    Jirácek J; Yiotakis A; Vincent B; Checler F; Dive V
    J Biol Chem; 1996 Aug; 271(32):19606-11. PubMed ID: 8702656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
    Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
    J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.
    Yiotakis A; Lecoq A; Nicolaou A; Labadie J; Dive V
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):323-7. PubMed ID: 7945258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphinic peptides as potent inhibitors of zinc-metalloproteases.
    Georgiadis D; Dive V
    Top Curr Chem; 2015; 360():1-38. PubMed ID: 25370521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
    Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
    Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.
    Yiallouros I; Vassiliou S; Yiotakis A; Zwilling R; Stöcker W; Dive V
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):375-9. PubMed ID: 9531473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphinic peptides as zinc metalloproteinase inhibitors.
    Dive V; Georgiadis D; Matziari M; Makaritis A; Beau F; Cuniasse P; Yiotakis A
    Cell Mol Life Sci; 2004 Aug; 61(16):2010-9. PubMed ID: 15316651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.
    Makaritis A; Georgiadis D; Dive V; Yiotakis A
    Chemistry; 2003 May; 9(9):2079-94. PubMed ID: 12740857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active methylene phosphinic peptides: a new diversification approach.
    Matziari M; Nasopoulou M; Yiotakis A
    Org Lett; 2006 May; 8(11):2317-9. PubMed ID: 16706515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
    Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
    J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
    Matziari M; Beau F; Cuniasse P; Dive V; Yiotakis A
    J Med Chem; 2004 Jan; 47(2):325-36. PubMed ID: 14711305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective inhibition of zinc aminopeptidase A (EC 3.4.11.7, APA) by glutamyl aminophosphinic peptides: importance of glutamyl aminophosphinic residue in the P1 position.
    Georgiadis D; Vazeux G; Llorens-Cortes C; Yiotakis A; Dive V
    Biochemistry; 2000 Feb; 39(5):1152-5. PubMed ID: 10653662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of potent inhibitors of botulinum neurotoxin type B.
    Anne C; Turcaud S; Quancard J; Teffo F; Meudal H; Fournié-Zaluski MC; Roques BP
    J Med Chem; 2003 Oct; 46(22):4648-56. PubMed ID: 14561084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase.
    Yiotakis A; Lecoq A; Vassiliou S; Raynal I; Cuniasse P; Dive V
    J Med Chem; 1994 Aug; 37(17):2713-20. PubMed ID: 8064799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solvents.
    Matziari M; Dellis D; Dive V; Yiotakis A; Samios J
    J Phys Chem B; 2010 Jan; 114(1):421-8. PubMed ID: 20014753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional structure of cyclohexapeptides containing a phosphinic bond in aqueous solution: a template for zinc metalloprotease inhibitors. A NMR and restrained molecular dynamics study.
    Cuniasse P; Raynal I; Lecoq A; Yiotakis A; Dive V
    J Med Chem; 1995 Feb; 38(3):553-64. PubMed ID: 7853348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and comparative study on the reactivity of peptidyl-type phosphinic esters: intramolecular effects in the alkaline and acidic cleavage of methyl beta-carboxyphosphinates.
    Georgiadis D; Dive V; Yiotakis A
    J Org Chem; 2001 Oct; 66(20):6604-10. PubMed ID: 11578210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids.
    Steer D; Lew R; Perlmutter P; Smith AI; Aguilar MI
    Biochemistry; 2002 Sep; 41(35):10819-26. PubMed ID: 12196021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.